Medicare Enrolled
Dr. Jonathan Eskenazi, MD
Neurology · Beverly Hills, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eskenazi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eskenazi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eskenazi
Dr. Jonathan Eskenazi is a neurology specialist in Beverly Hills, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Eskenazi performed 20,113 Medicare services across 7,632 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eskenazi received a total of $96,298 from 80 pharmaceutical and/or device companies across 1313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eskenazi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 5% volume in CA
$96,298 industry payments
Medicare Practice Summary
Medicare Utilization ↗20,113
Medicare services
Top 5% in CA for neurology
7,632
Unique beneficiaries
$142
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,676 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
9,206 | $100 | $745 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,440 | $106 | $516 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
1,114 | $145 | $895 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
560 | $10 | $27 |
| Physical therapy exercise, per 15 min A therapy session using exercises to improve strength, endurance, range of motion, and flexibility. Each 15-minute unit is billed separately. |
555 | $26 | $103 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
530 | $117 | $370 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
526 | $177 | $900 |
| Video EEG monitoring, 12-26 hours Continuous monitoring of brain wave activity combined with video recording for 12 to 26 hours. |
516 | $1,046 | $4,500 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
472 | $410 | $1,535 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
423 | $94 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
351 | $134 | $559 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
314 | $204 | $990 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
314 | $149 | $603 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
311 | $196 | $565 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
302 | $88 | $330 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
181 | $238 | $750 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity using an electroencephalogram (EEG) while simultaneously capturing video footage for a duration of 2 to 12 hours with intermittent monitoring. |
181 | $407 | $1,500 |
| Video EEG monitoring, 61-84 hours This procedure involves monitoring brain wave activity using an electroencephalogram (EEG) while simultaneously recording video for a duration of 61 to 84 hours. A healthcare professional reviews the data and provides a report. |
181 | $269 | $1,085 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 159 | $57 | $190 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
130 | $25 | $136 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
115 | $30 | $216 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
44 | $121 | $550 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
41 | $156 | $665 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $154 | $473 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
27 | $188 | $800 |
| New patient office visit, complex (60-74 min) | 25 | $179 | $714 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
22 | $253 | $1,050 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
18 | $154 | $650 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
14 | $219 | $900 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
14.3% medium
85.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$96,298
Total received (2018-2024)
Avg $13,757/year across 7 years
Top 7% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,313
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$66,245 (68.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,053 (31.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,215
2023
$14,551
2022
$13,165
2021
$21,321
2020
$21,366
2019
$6,959
2018
$8,722
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$869
UCB, Inc.
$844
Alexion Pharmaceuticals, Inc.
$817
SK Life Science, Inc.
$813
Neurelis, Inc.
$662
Lilly USA, LLC
$592
CATALYST PHARMACEUTICALS, INC.
$568
Celgene Corporation
$550
LivaNova USA, Inc.
$528
Novartis Pharmaceuticals Corporation
$483
Tonix Medicines, Inc.
$431
HARMONY BIOSCIENCES LLC
$313
Genentech USA, Inc.
$286
ABBVIE INC.
$226
ARGENX US, INC.
$223
Abbott Laboratories
$203
MDD US Operations, LLC
$189
Kyowa Kirin, Inc.
$160
Sumitomo Pharma America, Inc.
$135
JAZZ PHARMACEUTICALS INC.
$131
SCILEX PHARMACEUTICALS INC.
$116
Eisai Inc.
$114
Mylan Specialty L.P.
$100
Mallinckrodt Hospital Products Inc.
$91
Janssen Pharmaceuticals, Inc
$86
ANI Pharmaceuticals, Inc.
$84
Harmony Biosciences Llc
$79
Otsuka America Pharmaceutical, Inc.
$75
CSL Behring
$71
PFIZER INC.
$55
Biogen, Inc.
$53
OWP Pharmaceuticals, Inc.
$48
MITSUBISHI TANABE PHARMA AMERICA, INC.
$29
GE HEALTHCARE
$27
ACADIA Pharmaceuticals Inc
$26
Aucta Pharmaceuticals, Inc.
$25
EMD Serono, Inc.
$24
NEUROPACE, INC.
$22
Xeris Pharmaceuticals, Inc.
$19
Currax Pharmaceuticals LLC
$17
Metacel Pharmaceuticals LLC
$16
IDORSIA PHARMACEUTICALS US INC
$15
Top 3 companies account for 24.8% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$25,640
ABBVIE INC.
$17,710
AbbVie Inc.
$12,125
Amgen Inc.
$10,694
Allergan, Inc.
$4,026
Lilly USA, LLC
$1,872
SK Life Science, Inc.
$1,662
Neurocrine Biosciences, Inc.
$1,542
UCB, Inc.
$1,474
Novartis Pharmaceuticals Corporation
$1,424
Alexion Pharmaceuticals, Inc.
$1,390
Celgene Corporation
$1,354
Biogen, Inc.
$1,247
Mallinckrodt Hospital Products Inc.
$1,044
LivaNova USA, Inc.
$743
ARGENX US, INC.
$739
Avanir Pharmaceuticals, Inc.
$717
Neurelis, Inc.
$692
CATALYST PHARMACEUTICALS, INC.
$607
Genentech USA, Inc.
$593
GENZYME CORPORATION
$562
US WorldMeds, LLC
$530
Sumitomo Pharma America, Inc.
$475
Abbott Laboratories
$443
Tonix Medicines, Inc.
$431
Eisai Inc.
$410
Harmony Biosciences LLC
$381
Almatica Pharma LLC
$365
MDD US Operations, LLC
$341
Otsuka America Pharmaceutical, Inc.
$323
HARMONY BIOSCIENCES LLC
$313
Medtronic Vascular, Inc.
$285
Scilex Pharmaceuticals Inc.
$270
IMPEL PHARMACEUTICALS INC.
$268
E.R. Squibb & Sons, L.L.C.
$250
Allergan Inc.
$212
Janssen Pharmaceuticals, Inc
$209
IDORSIA PHARMACEUTICALS US INC
$207
MITSUBISHI TANABE PHARMA AMERICA, INC.
$168
Kyowa Kirin, Inc.
$160
JAZZ PHARMACEUTICALS INC.
$160
Nevro Corp.
$124
Ipsen Biopharmaceuticals, Inc
$117
SCILEX PHARMACEUTICALS INC.
$116
ACADIA Pharmaceuticals Inc
$115
Merz North America, Inc.
$111
Lundbeck LLC
$111
CSL Behring
$104
Mylan Specialty L.P.
$100
Sunovion Pharmaceuticals Inc.
$99
ANI Pharmaceuticals, Inc.
$84
Horizon Therapeutics plc
$81
PFIZER INC.
$80
Harmony Biosciences Llc
$79
Medtronic, Inc.
$77
Catalyst Pharmaceuticals, Inc.
$73
Supernus Pharmaceuticals, Inc.
$71
Arbor Pharmaceuticals, Inc.
$57
Axsome Therapeutics, Inc.
$50
MERZ NORTH AMERICA, INC.
$50
EMD Serono, Inc.
$49
OWP Pharmaceuticals, Inc.
$48
Azurity Pharmaceuticals, Inc.
$42
Medtronic USA, Inc.
$39
Corium, LLC
$30
Amneal Pharmaceuticals LLC
$30
GE HEALTHCARE
$27
Marinus Pharmaceuticals, Inc.
$26
Mallinckrodt Enterprises LLC
$26
Aucta Pharmaceuticals, Inc.
$25
Bausch Health US, LLC
$25
Merz Pharmaceuticals, LLC
$24
Biohaven Pharmaceuticals, Inc.
$23
NEUROPACE, INC.
$22
Amarin Pharma Inc.
$22
TG THERAPEUTICS, INC.
$20
Xeris Pharmaceuticals, Inc.
$19
Currax Pharmaceuticals LLC
$17
Impax Laboratories, Inc.
$17
Metacel Pharmaceuticals LLC
$16
Top 3 companies account for 57.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Activase · Adlarity · Aimovig · Apokyn · BOTOX · BRIUMVI · Briviact · Corlanor · Dysport · EMGALITY · EPIDIOLEX · Evrysdi · FIRDAPSE · FYCOMPA · Fintepla · GOCOVRI · GRALISE · Gocovri · Hizentra · Horizant · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · Leqembi · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONZETRA XSAIL · Ocrevus · Ocrevus Zunovo · Omnia · Ongentys · Ozobax · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Proclaim Family of SCS IPGs · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RNS Neurostimulator Kit · RYTARY · Repatha · Reveal LINQ · Rystiggo · SKYCLARYS · SPRAVATO · Soliris · Subvenite · Sunosi · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vascepa · WAKIX · Wakix · XADAGO · XARELTO · XCOPRI · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTALMY · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology in CA.
Geographic Context
Neurologists within 10 mi
548
Per 100K population
5.6
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eskenazi is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with speaking/promotional industry engagement in the top 7% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eskenazi experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Eskenazi performed 9,206 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eskenazi receive payments from pharmaceutical companies?
Yes. Dr. Eskenazi received a total of $96,298 from 80 companies across 1,313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eskenazi's costs compare to other neurologists in Beverly Hills?
Dr. Eskenazi's average Medicare payment per service is $142. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eskenazi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Beverly Hills
Browse neurologists in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology